Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration.

Cutaneous leishmaniasis (CL) is caused by Leishmania infection of dermal macrophages and is associated with chronic inflammation of the skin. L. aethiopica infection displays two clinical manifestations, firstly ulcerative disease, correlated to a relatively low parasite load in the skin, and second...

Full description

Bibliographic Details
Main Authors: Geremew Tasew, Susanne Nylén, Thorsten Lieke, Befekadu Lemu, Hailu Meless, Nicolas Ruffin, Dawit Wolday, Abraham Asseffa, Hideo Yagita, Sven Britton, Hannah Akuffo, Francesca Chiodi, Liv Eidsmo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-01-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC2953481?pdf=render
_version_ 1819129414141607936
author Geremew Tasew
Susanne Nylén
Thorsten Lieke
Befekadu Lemu
Hailu Meless
Nicolas Ruffin
Dawit Wolday
Abraham Asseffa
Hideo Yagita
Sven Britton
Hannah Akuffo
Francesca Chiodi
Liv Eidsmo
author_facet Geremew Tasew
Susanne Nylén
Thorsten Lieke
Befekadu Lemu
Hailu Meless
Nicolas Ruffin
Dawit Wolday
Abraham Asseffa
Hideo Yagita
Sven Britton
Hannah Akuffo
Francesca Chiodi
Liv Eidsmo
author_sort Geremew Tasew
collection DOAJ
description Cutaneous leishmaniasis (CL) is caused by Leishmania infection of dermal macrophages and is associated with chronic inflammation of the skin. L. aethiopica infection displays two clinical manifestations, firstly ulcerative disease, correlated to a relatively low parasite load in the skin, and secondly non-ulcerative disease in which massive parasite infiltration of the dermis occurs in the absence of ulceration of epidermis. Skin ulceration is linked to a vigorous local inflammatory response within the skin towards infected macrophages. Fas ligand (FasL) and Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expressing cells are present in dermis in ulcerative CL and both death ligands cause apoptosis of keratinocytes in the context of Leishmania infection. In the present report we show a differential expression of FasL and TRAIL in ulcerative and non-ulcerative disease caused by L. aethiopica. In vitro experiments confirmed direct FasL- and TRAIL-induced killing of human keratinocytes in the context of Leishmania-induced inflammatory microenvironment. Systemic neutralisation of FasL and TRAIL reduced ulceration in a model of murine Leishmania infection with no effect on parasitic loads or dissemination. Interestingly, FasL neutralisation reduced neutrophil infiltration into the skin during established infection, suggesting an additional proinflammatory role of FasL in addition to direct keratinocyte killing in the context of parasite-induced skin inflammation. FasL signalling resulting in recruitment of activated neutrophils into dermis may lead to destruction of the basal membrane and thus allow direct FasL mediated killing of exposed keratinocytes in vivo. Based on our results we suggest that therapeutic inhibition of FasL and TRAIL could limit skin pathology during CL.
first_indexed 2024-12-22T08:43:20Z
format Article
id doaj.art-95283ef4731c4cb098c92a31621b17de
institution Directory Open Access Journal
issn 1935-2735
language English
last_indexed 2024-12-22T08:43:20Z
publishDate 2010-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-95283ef4731c4cb098c92a31621b17de2022-12-21T18:32:10ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27352010-01-01410e84410.1371/journal.pntd.0000844Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration.Geremew TasewSusanne NylénThorsten LiekeBefekadu LemuHailu MelessNicolas RuffinDawit WoldayAbraham AsseffaHideo YagitaSven BrittonHannah AkuffoFrancesca ChiodiLiv EidsmoCutaneous leishmaniasis (CL) is caused by Leishmania infection of dermal macrophages and is associated with chronic inflammation of the skin. L. aethiopica infection displays two clinical manifestations, firstly ulcerative disease, correlated to a relatively low parasite load in the skin, and secondly non-ulcerative disease in which massive parasite infiltration of the dermis occurs in the absence of ulceration of epidermis. Skin ulceration is linked to a vigorous local inflammatory response within the skin towards infected macrophages. Fas ligand (FasL) and Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expressing cells are present in dermis in ulcerative CL and both death ligands cause apoptosis of keratinocytes in the context of Leishmania infection. In the present report we show a differential expression of FasL and TRAIL in ulcerative and non-ulcerative disease caused by L. aethiopica. In vitro experiments confirmed direct FasL- and TRAIL-induced killing of human keratinocytes in the context of Leishmania-induced inflammatory microenvironment. Systemic neutralisation of FasL and TRAIL reduced ulceration in a model of murine Leishmania infection with no effect on parasitic loads or dissemination. Interestingly, FasL neutralisation reduced neutrophil infiltration into the skin during established infection, suggesting an additional proinflammatory role of FasL in addition to direct keratinocyte killing in the context of parasite-induced skin inflammation. FasL signalling resulting in recruitment of activated neutrophils into dermis may lead to destruction of the basal membrane and thus allow direct FasL mediated killing of exposed keratinocytes in vivo. Based on our results we suggest that therapeutic inhibition of FasL and TRAIL could limit skin pathology during CL.http://europepmc.org/articles/PMC2953481?pdf=render
spellingShingle Geremew Tasew
Susanne Nylén
Thorsten Lieke
Befekadu Lemu
Hailu Meless
Nicolas Ruffin
Dawit Wolday
Abraham Asseffa
Hideo Yagita
Sven Britton
Hannah Akuffo
Francesca Chiodi
Liv Eidsmo
Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration.
PLoS Neglected Tropical Diseases
title Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration.
title_full Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration.
title_fullStr Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration.
title_full_unstemmed Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration.
title_short Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration.
title_sort systemic fasl and trail neutralisation reduce leishmaniasis induced skin ulceration
url http://europepmc.org/articles/PMC2953481?pdf=render
work_keys_str_mv AT geremewtasew systemicfaslandtrailneutralisationreduceleishmaniasisinducedskinulceration
AT susannenylen systemicfaslandtrailneutralisationreduceleishmaniasisinducedskinulceration
AT thorstenlieke systemicfaslandtrailneutralisationreduceleishmaniasisinducedskinulceration
AT befekadulemu systemicfaslandtrailneutralisationreduceleishmaniasisinducedskinulceration
AT hailumeless systemicfaslandtrailneutralisationreduceleishmaniasisinducedskinulceration
AT nicolasruffin systemicfaslandtrailneutralisationreduceleishmaniasisinducedskinulceration
AT dawitwolday systemicfaslandtrailneutralisationreduceleishmaniasisinducedskinulceration
AT abrahamasseffa systemicfaslandtrailneutralisationreduceleishmaniasisinducedskinulceration
AT hideoyagita systemicfaslandtrailneutralisationreduceleishmaniasisinducedskinulceration
AT svenbritton systemicfaslandtrailneutralisationreduceleishmaniasisinducedskinulceration
AT hannahakuffo systemicfaslandtrailneutralisationreduceleishmaniasisinducedskinulceration
AT francescachiodi systemicfaslandtrailneutralisationreduceleishmaniasisinducedskinulceration
AT liveidsmo systemicfaslandtrailneutralisationreduceleishmaniasisinducedskinulceration